Two signaling pathways can lead to Fas ligand expression in CD8(+) cytotoxic T lymphocyte clones

被引:41
作者
Anel, A [1 ]
Simon, AK [1 ]
Auphan, N [1 ]
Buferne, M [1 ]
Boyer, C [1 ]
Golstein, P [1 ]
SchmittVerhulst, AM [1 ]
机构
[1] CTR IMMUNOL,INSERM,CNRS MARSEILLE LUMINY,F-13288 MARSEILLE 09,FRANCE
关键词
Fas ligand; protein kinase C isoforms; nuclear factor-kappa B;
D O I
10.1002/eji.1830251227
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As shown previously, a given cytotoxic T lymphocyte (CTL) clone (KB5.C20) could be induced to express the Fas ligand (Fast) by either T cell receptor (TCR) engagement or phorbol 12-myristate 13-acetate (PMA)/ionomycin stimulation. In contrast, another CTL clone (BM3.3) has now been found to exert Fas-based cytotoxicity only after TCR engagement, but not after PMA/ionomycin stimulation. This suggested the existence of a PMA-insensitive, antigen-induced pathway leading to Fast expression. The inability of PMA to promote Fas-based cytotoxicity in BM3.3 cells was correlated with a defect in expression of the classical protein kinase C (PKC) isoforms alpha and beta I. In KB5.C20 cells depleted of PMA-sensitive PKC isoforms and thus no longer responsive to PMA, Fas-based cytotoxicity could still be induced via the TCR/CD3 pathway. On the other hand, a requirement for phosphatidylinositol-3 kinase (PI3K) selectively in this TCR/CD3-induced pathway was demonstrated by specific inhibition with wortmannin. These results suggest that Fast expression when induced via the TCR/CD3 involves PI3K, and when induced by PMA/ionomycin requires the expression of PMA-sensitive PKC isoforms absent in clone BM3.3. Additional data suggest that in neither case was NF-kappa B activation implicated in Fast expression.
引用
收藏
页码:3381 / 3387
页数:7
相关论文
共 37 条
  • [21] IDENTIFICATION OF A MONOCLONAL-ANTIBODY SPECIFIC FOR A MURINE T3 POLYPEPTIDE
    LEO, O
    FOO, M
    SACHS, DH
    SAMELSON, LE
    BLUESTONE, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (05) : 1374 - 1378
  • [22] CTLA-4 IS A 2ND RECEPTOR FOR THE B-CELL ACTIVATION ANTIGEN-B7
    LINSLEY, PS
    BRADY, W
    URNES, M
    GROSMAIRE, LS
    DAMLE, NK
    LEDBETTER, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) : 561 - 569
  • [23] HETEROGENEITY OF PROTEIN KINASE-C EXPRESSION AND REGULATION IN T-LYMPHOCYTES
    LUCAS, S
    MARAIS, R
    GRAVES, JD
    ALEXANDER, D
    PARKER, P
    CANTRELL, DA
    [J]. FEBS LETTERS, 1990, 260 (01) : 53 - 56
  • [24] THE FAS DEATH FACTOR
    NAGATA, S
    GOLSTEIN, P
    [J]. SCIENCE, 1995, 267 (5203) : 1449 - 1456
  • [25] NAKANISHI H, 1993, J BIOL CHEM, V268, P13
  • [26] NISHIMURA T, 1987, J IMMUNOL, V139, P2888
  • [27] INTRACELLULAR SIGNALING BY HYDROLYSIS OF PHOSPHOLIPIDS AND ACTIVATION OF PROTEIN-KINASE-C
    NISHIZUKA, Y
    [J]. SCIENCE, 1992, 258 (5082) : 607 - 614
  • [28] SEQUENTIAL ACTIVATION AND LETHAL HIT MEASURED BY [CA-2+]I IN INDIVIDUAL CYTOLYTIC T-CELLS AND TARGETS
    POENIE, M
    TSIEN, RY
    SCHMITTVERHULST, AM
    [J]. EMBO JOURNAL, 1987, 6 (08) : 2223 - 2232
  • [29] FAS INVOLVEMENT IN CA2+-INDEPENDENT T-CELL-MEDIATED CYTOTOXICITY
    ROUVIER, E
    LUCIANI, MF
    GOLSTEIN, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (01) : 195 - 200
  • [30] 2-STEP TCR-ZETA/CD3-CD4 AND CD28 SIGNALING IN T-CELLS - SH2/SH3 DOMAINS, PROTEIN-TYROSINE AND LIPID KINASES
    RUDD, CE
    JANSSEN, O
    CAI, YC
    DASILVA, AJ
    RAAB, M
    PRASAD, KVS
    [J]. IMMUNOLOGY TODAY, 1994, 15 (05): : 225 - 234